PT  - JOURNAL ARTICLE
AU  - Williams, Hants
AU  - Steinberg, Sarah
AU  - Leon, Kendall
AU  - O’Shea, Catherine
AU  - Berzin, Robin
AU  - Hagg, Heather
TI  - The Validity of the Parsley Symptom Index: an e-PROM designed for Telehealth
AID  - 10.1101/2022.04.15.22273917
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.15.22273917
4099  - http://medrxiv.org/content/early/2022/04/18/2022.04.15.22273917.short
4100  - http://medrxiv.org/content/early/2022/04/18/2022.04.15.22273917.full
AB  - Background / Purpose The Parsley Symptom Index (PSI) is a recently developed symptom assessment for adults with chronic disease in telehealth settings. The purpose of this study was to validate the PSI against the Self-Rated Health (SRH) item.Materials and Methods This prospective cohort study took place from January 15, 2021 to December 15, 2021 among a sample of 10,519 adult patients at Parsley Health, a subscription based holistic medical practice. The PSI and the SRH were completed by patients via an online portal. The association between the PSI and SRH was assessed via polyserial and polychoric correlations, while weighted kappa scores provided information related to agreement between the PSI and SRH.Results From 22,748 responses, there were moderate levels of association (polyserial r=0.51; polychoric r=0.52) and agreement (weighted □ = 0.46) between the PSI and SRH. In total 74.2% (16865) of responses between the PSI and SRH were relatively congruent while 36.2% (8229) were literally congruent.Conclusions The PSI demonstrates validity with the SRH for adults with chronic disease in a telehealth setting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee/IRB of Stony Brook University waived and considered this study exempt from 45 Code of Federal Regulations requirements (IRB2020-00429)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors